Tobacco seller Philip Morris International (PM) recently soared to new heights on the back of its blockbuster Q4 2024 ...

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $100.0 to $150.0 for Philip Morris Intl during the past quarter.

FDA authorizes the marketing of 20 Zyn products because they pose fewer health risks than cigarettes and most smokeless products Shares of Philip Morris International Inc. extended their recent ...

Philip Morris (PM) is set to report fourth-quarter earnings, with a focus on its smoke-free products as consumers shift to ...

Overall, the quarter highlighted Philip Morris's strategic shift towards smoke-free products, supporting a strong financial performance despite lingering reliance on traditional tobacco products.

Philip Morris International Inc.’s stock ... analyst expectations on strength in its smokeless-tobacco products. Philip Morris cited growth in Iqos, its inhalable smoke-free product, as well ...

Tobacco giant cites boost from smokeless products such as the Zyn nicotine pouch Philip Morris International Inc. issued a profit outlook that topped Wall Street analyst expectations on strength ...

Quarterly shipments of HTU and oral smoke-free products exceeded 40 billion units for the first time, driving our ...

Revenue rose 7.3% year-over-year during the quarter to $9.71 billion. On an organic basis, revenue was also up 7.3%. Total ...

Philip Morris International Inc. (PM)'s share was trading at $119.80 as of Jan 16 th. PM’s trailing and forward P/E were 19.02 and 17.24 respectively according to Yahoo Finance.

Philip Morris International Inc. PM is likely to ... from its significant strides toward a smoke-free future. Smoke-free products accounted for 38% of the company’s net revenues in the third ...

Shares of Philip Morris International Inc. extended their ... that the marketing approval doesn’t mean the agency believes the products are safe — only that they are safer than some alternatives.